Perfluorocarbon regulates the intratumoural environment to enhance hypoxia-based agent efficacy

Photoredox catalysis using infrared light via triplet fusion upconversion

(2019) Benjamin D. Ravetz et al.   NATURE

Progress and challenges towards targeted delivery of cancer therapeutics

(2018) Daniel Rosenblum et al.   Nature Communications

Near infrared photoimmunotherapy using a fiber optic diffuser for treating peritoneal gastric cancer dissemination

(2018) Tadanobu Nagaya et al.   Gastric Cancer

Perfluorocarbon Nanoparticles Mediated Platelet Blocking Disrupt Vascular Barriers to Improve the Efficacy of Oxygen-Sensitive Antitumor Drugs

(2018) Zaigang Zhou et al.   Small

Magnesium silicide nanoparticles as a deoxygenation agent for cancer starvation therapy

(2017) Chen Zhang et al.   Nature Nanotechnology

Toxicology and efficacy of tumor-targeting Salmonella typhimurium A1-R compared to VNP 20009 in a syngeneic mouse tumor model in immunocompetent mice

(2017) Yong Zhang et al.   Oncotarget

Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy

(2016) Liangzhu Feng et al.   ACS Nano

Ultrasound Triggered Tumor Oxygenation with Oxygen-Shuttle Nanoperfluorocarbon to Overcome Hypoxia-Associated Resistance in Cancer Therapies

(2016) Xuejiao Song et al.   NANO LETTERS

Hypoxia Induced by Upconversion-Based Photodynamic Therapy: Towards Highly Effective Synergistic Bioreductive Therapy in Tumors

(2015) Yanyan Liu et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Radiation-/hypoxia-induced solid tumor metastasis and regrowth inhibited by hypoxia-specific upconversion nanoradiosensitizer

(2015) Yanyan Liu et al.   BIOMATERIALS

Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy

(2015) Yuhao Cheng et al.   Nature Communications

PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation

(2014) Muhammad Zaeem Noman et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis

(2014) Y. Kim et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Novel Self-assembly Endows Human Serum Albumin Nanoparticles with an Enhanced Antitumor Efficacy

(2013) Dawei Ding et al.   AAPS PHARMSCITECH

Strategies for advancing cancer nanomedicine

(2013) Vikash P. Chauhan et al.   NATURE MATERIALS

Microenvironmental regulation of tumor progression and metastasis

(2013) Daniela F Quail et al.   NATURE MEDICINE

Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels

(2013) Vikash P. Chauhan et al.   Nature Communications

In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers

(2012) Niagara Muhammad Idris et al.   NATURE MEDICINE

Intracellular O2 Sensing Probe Based on Cell-Penetrating Phosphorescent Nanoparticles

(2011) Andreas Fercher et al.   ACS Nano

T cell augments the antitumor activity of tumor-targeting Salmonella

(2011) Che-Hsin Lee et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

In tumors Salmonella migrate away from vasculature toward the transition zone and induce apoptosis

(2011) S Ganai et al.   CANCER GENE THERAPY

Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of TH-302, a Hypoxia-Activated Prodrug, in Patients with Advanced Solid Malignancies

(2011) G. J. Weiss et al.   CLINICAL CANCER RESEARCH

Tumour necrosis factor-alpha increases extravasation of virus particles into tumour tissue by activating the Rho A/Rho kinase pathway

(2011) Takahiro Seki et al.   JOURNAL OF CONTROLLED RELEASE

How platelets safeguard vascular integrity

(2011) B. HO-TIN-NOÉ et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Fabrication of a nanocarrier system through self-assembly of plasma protein and its tumor targeting

(2011) Guangming Gong et al.   NANOTECHNOLOGY

A Phase I Study of the Safety and Pharmacokinetics of the Hypoxia-Activated Prodrug TH-302 in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma

(2011) Kristen N. Ganjoo et al.   ONCOLOGY

Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer

(2010) R. K. Shrimali et al.   CANCER RESEARCH

Vessel destruction by tumor-targetingSalmonella typhimuriumA1-R is enhanced by high tumor vascularity

(2010) Fang Liu et al.   CELL CYCLE

Tumour Targeting with Systemically Administered Bacteria

(2010) David Morrissey et al.   CURRENT GENE THERAPY

Platelets: Guardians of Tumor Vasculature

(2009) B. Ho-Tin-Noe et al.   CANCER RESEARCH

In vivo activation of the hypoxia-targeted cytotoxin AQ4N in human tumor xenografts

(2009) K. J. Williams et al.   MOLECULAR CANCER THERAPEUTICS

Platelet Granule Secretion Continuously Prevents Intratumor Hemorrhage

(2008) B. Ho-Tin-Noe et al.   CANCER RESEARCH

Tirapazamine: a novel agent targeting hypoxic tumor cells

(2008) Srini B Reddy et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS